EUVIMEDEUVIMED entdecken
Open Access

Outcomes of Partial Oral Antibiotic Treatment for Complicated Staphylococcus aureus Bacteremia in People Who Inject Drugs

John A Wildenthal, Andrew Atkinson, Sophia Lewis, Sena Sayood iD, Nathanial S Nolan, Nicolo L Cabrera, Jonas Marschall, Michael J Durkin, Laura R Marks iD

Clinical Infectious Diseases · 08.02.2023 · 76 (3) · 487-496

DOI: 10.1093/cid/ciac714 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 02.09.2022. Verfasst von John A Wildenthal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medical Scientist Training Program, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Drug Users, Substance Abuse, Intravenous, Staphylococcal Infections, Bacteremia. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCR NIH HHS, NCATS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Staphylococcus aureus represents the leading cause of complicated bloodstream infections among persons who inject drugs (PWID). Standard of care (SOC) intravenous (IV) antibiotics result in high rates of treatment success but are not feasible for some PWID. Transition to oral antibiotics may represent an alternative treatment option.

Methods

We evaluated all adult patients with a history of injection drug use hospitalized from January 2016 through December 2021 with complicated S. aureus bloodstream infections, including infective endocarditis, epidural abscess, vertebral osteomyelitis, and septic arthritis. Patients were compared by antibiotic treatment (standard of care intravenous [SOC IV] antibiotics, incomplete IV therapy, or transition from initial IV to partial oral) using the primary composite endpoint of death or readmission from microbiologic failure within 90 days of discharge.

Results

Patients who received oral antibiotics after an incomplete IV antibiotic course were significantly less likely to experience microbiologic failure or death than patients discharged without oral antibiotics (P < .001). There was no significant difference in microbiologic failure rates when comparing patients who were discharged on partial oral antibiotics after receiving at least 10 days of IV antibiotics with SOC regimens (P > .9).

Conclusions

Discharge of PWID with partially treated complicated S. aureus bacteremias without oral antibiotics results in high rates of morbidity and should be avoided. For PWID hospitalized with complicated S. aureus bacteremias who have received at least 10 days of effective IV antibiotic therapy after clearance of bacteremia, transition to oral antibiotics with outpatient support represents a potential alternative if the patient does not desire SOC IV antibiotic therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug UsersSubstance Abuse, IntravenousStaphylococcal InfectionsBacteremiaAdultHumansAnti-Bacterial AgentsStaphylococcus aureusRetrospective Studies

Stichwörter der Autor:innen

Staphylococcus aureusendocarditisopioid use disorderosteomyelitissubstance abuse

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Medical Scientist Training Program, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
  • Division of Infectious Diseases, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
  • Department of Computational and Systems Biology, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
  • Department of Infectious Diseases, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland.

ORCID-Profile: Sena Sayood, Laura R Marks

Förderung

  • NIDCR NIH HHS
  • NCATS NIH HHS
  • National Institutes of Health
  • Swiss National Science Foundation

Zitieren

APA

Wildenthal, J. A., Atkinson, A., Lewis, S., Sayood, S., Nolan, N. S., Cabrera, N. L., Marschall, J., Durkin, M. J., & Marks, L. R. (2023). Outcomes of Partial Oral Antibiotic Treatment for Complicated Staphylococcus aureus Bacteremia in People Who Inject Drugs. Clinical Infectious Diseases, 76(3), 487-496. https://doi.org/10.1093/cid/ciac714

Vancouver

Wildenthal JA, Atkinson A, Lewis S, Sayood S, Nolan NS, Cabrera NL, et al. Outcomes of Partial Oral Antibiotic Treatment for Complicated Staphylococcus aureus Bacteremia in People Who Inject Drugs. Clinical Infectious Diseases. 2023;76(3):487-496. doi:10.1093/cid/ciac714

BibTeX
@article{Wildenthal2023,
  author = {Wildenthal, John A and Atkinson, Andrew and Lewis, Sophia and Sayood, Sena and Nolan, Nathanial S and Cabrera, Nicolo L and Marschall, Jonas and Durkin, Michael J and Marks, Laura R},
  title = {Outcomes of Partial Oral Antibiotic Treatment for Complicated Staphylococcus aureus Bacteremia in People Who Inject Drugs},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  volume = {76},
  number = {3},
  pages = {487--496},
  doi = {10.1093/cid/ciac714}
}
Kostenlos starten →